Related by context. Frequent words. (Click for all words.) 60 RXi Pharmaceutical Corporation 59 risks anduncertainties 58 concerning Alnylam 57 Statements Certain 57 Nanobac Pharmaceuticals Inc. 57 forward lookingstatements 56 suchforward looking 56 theforward looking 56 differmaterially 56 Resverlogix Corp. 56 iCo Therapeutics 55 TranSwitch indebtedness 55 Hybridon 54 Statements Statements 54 R sorafenib tablets 54 OctoPlus NV 54 OR SIMILAR STATEMENTS ARE 54 prostones 53 DISCLOSURE NOTICE 53 Assumptions relating 53 www.norsat.com 53 bafetinib 52 PrivateSecurities Litigation Reform Act 52 ELADUR 52 Allovectin 7 R 52 www.tekmirapharm.com 52 Opexa Therapeutics 52 Myrexis 51 * Potentially libelous 51 yet determinable 51 Entereg R 51 Regulus 51 colorectal lung 51 Ardea Biosciences 51 SANCTURA R 51 transportation storage terminalling 51 www.exelixis.com 51 Bioenvision compounds under 51 Genetronics 51 Zalicus 51 ZEGERID Powder 51 TRANSDUR Sufentanil 51 BLA submission 50 theSecurities 50 ELEVESS 50 ZEGERID ® 50 TOCOSOL Paclitaxel 50 Eligard R 50 Applera Corporation 50 Kuvan R 50 InKine 50 CONTAINS FORWARD LOOKING STATEMENTS 50 vernakalant oral 50 FermaVir 50 Topical Interferon Alpha 2b 50 PharmaFrontiers 50 pulmonology portfolio 50 Gilead assumes 50 ADVISORY Certain information 50 CorMedix 50 Rexahn 50 ACS disclaims 50 intents beliefs 50 expectations anticipations estimates 50 Inovio clinical 50 visit www.oncolyticsbiotech.com 49 CompanyaEUR TM s 49 Aegerion 49 forward.looking statements 49 CAUTIONARY STATEMENT 49 Oncolytics please 49 autoimmune indications 49 MedCom USA Inc. 49 reflect Sentry Select 49 FORWARD LOOKING STATEMENT 49 Gemin X 49 ovarian breast 49 Looking Statements Certain 49 MOZOBIL 49 Nventa 49 Caution Regarding Forward Looking 49 StratoComm Corporation 49 OSI Pharmaceuticals filings 49 goals expectations anticipations 49 VIRxSYS 49 Daytrana TM 49 www.thqwireless.com 49 FavId 49 Cautionary Notice 49 Ceragenix 49 Rasilez Tekturna 49 Actual results 49 InSite Vision 49 Symphony tCGM System 49 please visit http:/www.gene.com 49 HIV associated lipodystrophy 49 Mipomersen 49 outlicensing 48 SCHERING PLOUGH DISCLOSURE NOTICE 48 Tranzyme Pharma 48 CAUTIONARY STATEMENT REGARDING FORWARD